Evidence map›Paper›PMID 30799433›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Pyridoxamine Treatment of HK-2 Human Proximal Tubular Epithelial Cells Reduces Oxidative Stress and the Inhibition of Autophagy Induced by High Glucose Levels.

Ying Wang, Ying Li, Zhiping Yang, Ziqiang Wang, Jiang Chang, Tao Zhang, Yanqing Chi, Ning Han, Kunxiao Zhao

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Oxidative Stress Effects of Soluble Sulfide on Human Hepatocyte Cell Line LO2.International journal of environmental research and public health · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Ying WangDepartment of Nephrology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (mainland).
Ying LiDepartment of Nephrology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (mainland).
Zhiping YangDepartment of Urinary Surgery, Bayannur City Hospital, Bayannaoer, Inner Mongolia, China (mainland).
Ziqiang WangDepartment of Nephrology, Cangzhou People's Hospital, Cangzhou, Hebei, China (mainland).
Jiang ChangDepartment of Hepatobiliary Surgery, Bayannur City Hospital, Bayannaoer, Inner Mongolia, China (mainland).
Tao ZhangDepartment of Nephrology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (mainland).
Yanqing ChiDepartment of Nephrology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (mainland).
Ning HanDepartment of Nephrology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (mainland).
Kunxiao ZhaoDepartment of Nephrology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (mainland).
Hebei Medical University · CNInner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine · CNThird Hospital of Hebei Medical University · CNPeople's Hospital of Cangzhou · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Diabetic nephropathy is a predominant cause of renal failure, which is an important chronic complication of diabetes. Pyridoxamine (PM) has been reported to protect renal tubular epithelial cells against oxidative damage and delay or inhibit the development and generation of glucose-induced renal insufficiency at the early stage of disease. In this study, we attempted to explore the protection mechanism of PM on human proximal tubular epithelial cells (HK-2 cells) induced by high glucose. MATERIAL AND METHODS HK-2 cells were cultivated by high glucose medium in the absence or presence of PM. Cell Counting Kit-8 was used to investigate the most appropriate drug concentration of PM by detecting the cell viability of HK-2 cells. The expression of autophagy-related protein Beclin-1, LC-3II, and p62 was measured by western blot analysis, reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR), and immunofluorescence. The expression and localization of Beclin-1 and p62 were also detected via immunofluorescence. The intracellular reactive oxygen species generation was detected using the reactive oxygen species assay kit. The effects of PM on antioxidant defenses were evaluated with glutathione peroxidase (GPx), manganese superoxide dismutase (MnSOD) activity, and glutathione/glutathione disulfide (GSH/GSSG) ratio. RESULTS High glucose levels were able to upregulate the expression of oxidative stress associated protein and inhibit autophagy‑associated changes verified by western blotting, RT‑qPCR and immunofluorescence. Administration of PM reversed the high glucose‑induced low-expressed Beclin-1 and LC-3II, and overexpressed p62 and intracellular reactive oxygen species levels. Furthermore, non-enzymatic antioxidant defenses and enzymatic antioxidant defenses were turned on by the application of PM. CONCLUSIONS Treatment with PM could reverse high glucose-induced inhibition of autophagy and oxidative stress.

Indexed as

ApoptosisAutophagyCell LineCell SurvivalEpithelial CellsGlucoseGlutathione PeroxidaseHumansKidney Tubules, ProximalOxidation-ReductionOxidative StressPyridoxamineReactive Oxygen SpeciesGlucoseGlutathione PeroxidasePyridoxamineReactive Oxygen Species

Identifiers

PMID30799433
PMCPMC6400021
OpenAlexW2917686382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.